Allergan Snaps Up Sydney Biotech for Upfront Payment of US $95M
Elastagen's revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin. Source: BioSpace
Elastagen's revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin. Source: BioSpace
This biotech could potentially could be a better value. Source: BioSpace
It's starting to feel like Teva can't catch a break. Source: BioSpace
The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace
Sanofi is ending a mid-stage program for isatuximab for acute lymphoblastic leukemia, and SAR428926, an anti-LAMP1 ADC for solid tumors. Source: BioSpace
Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn. Source: BioSpace
The company presented a late-breaker poster and corresponding oral presentation at the conference. Source: BioSpace
The FDA approved Gilead's triple combination treatment for HIV, Biktarvy. Source: BioSpace
Here is some insight on what Vertex may be looking for in their employees. Source: BioSpace
MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace